SCHEMBL7915709

SCHEMBL7915709

Cc1ccccc1C(=O)c1cccc2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.65
NR4A1 P22736 1/20 0.57
NR4A2 P43354 1/20 0.57
NR4A3 Q92570 1/20 0.57
CNR2 P34972 6/20 0.56
PLK1 P53350 1/20 0.55
ALDH1A1 P00352 1/20 0.54
CYP2A6 P11509 1/20 0.54
MEN1 O00255 1/20 0.53
MAPT P10636 1/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C19 P33261 1/20 0.53
MMP3 P08254 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
CNR1 P21554 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28346219 0.89 CDC25B (0.61) CDC25BNR4A1NR4A2NR4A3CNR2
SCHEMBL244802 0.88 CDC25B (0.80) CDC25BNR4A1NR4A2NR4A3CNR2
SCHEMBL29414437 0.88 CDC25B (0.80) CDC25BNR4A1NR4A2NR4A3CNR2
Hydrochloric Acid SCHEMBL27713225 0.86 CDC25B (0.77) CDC25BNR4A1NR4A2NR4A3CNR2
SCHEMBL13625861 0.85 CDC25B (0.61) CDC25BNR4A1NR4A2NR4A3CNR2
SCHEMBL333141 0.83 CYP3A4 (0.55) ALDH1A1MAPTHTTKMT2ACYP3A4
SCHEMBL29387256 0.83 CYP3A4 (0.55) ALDH1A1MAPTHTTKMT2ACYP3A4
SCHEMBL9360719 0.81 CDC25B (0.70) CDC25BNR4A1NR4A2NR4A3CNR2
SCHEMBL10669335 0.81 CYP3A4 (0.59) ALDH1A1MAPTHTTKMT2ACYP3A4
SCHEMBL6238903 0.80 BCL2L1 (0.55) CDC25BNR4A1NR4A2NR4A3CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9328300-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2016-05-03 US claimed
WO-1995020637-A2 HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) 1995-08-03 WO claimed
US-10106752-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2018-10-23 US disclosed
US-20170037327-A1 METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2017-02-09 US disclosed
US-9328300-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2016-05-03 US disclosed
US-20110059948-A1 QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS THE INSTITUTE OF MOLECULAR MEDICINE (IN) 2011-03-10 US disclosed
US-20110059948-A1 QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS THE INSTITUTE OF MOLECULAR MEDICINE (IN) 2011-03-10 US disclosed
WO-2009091324-A1 QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATES AS ANTI-MYCOBACTERIAL AGENTS CHATTOPADHYAYA JYOTI (SE) 2009-07-23 WO disclosed
EP-0872903-B1 Method for making hydrogen storage alloy powder and electrode comprising the alloy powder SHINETSU CHEMICAL CO (JP) 2001-10-04 EP disclosed
US-6277519-B1 QUENCHING AN ALLOY MELT; COMMINUTION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2001-08-21 US disclosed
US-6096144-A TREATING WITH ACIDIC OR ALKALINE SOLUTION OF CONJUGATED UNSATURATED COMPOUND WITH AT LEAST 5 BONDS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2000-08-01 US disclosed
EP-0172427-B1 PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER Shin-Etsu Chemical Co., Ltd. (JP) 1989-07-05 EP disclosed
US-4764635-A Aromatization process ETHYL CORPORATION (US) 1988-08-16 US disclosed
US-4762943-A Aromatization process ETHYL CORPORATION (US) 1988-08-09 US disclosed
US-4758639-A Process for production of vinyl polymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-19 US disclosed
US-4757124-A Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-12 US disclosed
EP-0256849-A1 Aromatization process ETHYL CORPORATION (US) 1988-02-24 EP disclosed
EP-0254422-A1 Aromatization process ETHYL CORPORATION (US) 1988-01-27 EP disclosed
CN-87102669-A Fiberboard and manufacture method thereof 1987-12-30 CN disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059948-A1 QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS NQO1, NQO2, NDUFV1 CDC25B 1159/4885NR4A1 379/4885NR4A2 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.